Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.96 HKD | +0.25% | +20.73% | -24.71% |
Mar. 21 | Sisram Medical’s Profit Down in Fiscal 2023 | MT |
Mar. 20 | Sisram Medical Ltd Announces Ordinary Final Cash Dividend for the Year Ended December 31, 2023 | CI |
Sales 2024 * | 394M 3.08B | Sales 2025 * | 438M 3.42B | Capitalization | 237M 1.85B |
---|---|---|---|---|---|
Net income 2024 * | 35M 274M | Net income 2025 * | 40M 313M | EV / Sales 2024 * | 0.6 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.54 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 1,080 |
Yield 2024 * |
3.96% | Yield 2025 * |
5.94% | Free-Float | 28.43% |
1 day | +0.76% | ||
1 week | +22.46% | ||
Current month | +12.75% | ||
1 month | +11.80% | ||
3 months | -4.10% | ||
6 months | -26.02% | ||
Current year | -24.33% |
Managers | Title | Age | Since |
---|---|---|---|
Lior Moshe Dayan
CEO | Chief Executive Officer | 54 | 17-06-05 |
Nikol Lev
CTO | Chief Tech/Sci/R&D Officer | - | - |
Itay Meir
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Heung Sang Fong
BRD | Director/Board Member | 64 | 16-12-31 |
Yi Fang Wu
BRD | Director/Board Member | 54 | 16-10-16 |
Lior Moshe Dayan
CEO | Chief Executive Officer | 54 | 17-06-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 7 M€ | +2.57% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 3.96 | +0.25% | 700 400 |
24-05-02 | 3.95 | +7.34% | 1,188,400 |
24-04-30 | 3.68 | -0.54% | 824,800 |
24-04-29 | 3.7 | +4.52% | 1,796,007 |
24-04-26 | 3.54 | +7.93% | 1,493,200 |
Delayed Quote Hong Kong S.E., May 03, 2024 at 03:37 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.33% | 237M | |
+21.64% | 1B | |
-27.57% | 85.63M |
- Stock Market
- Equities
- 1696 Stock